Jayant Acharya, MD

Neurologist and Epilepsy Specialist, Co-Executive Director of the Neuroscience Institute
Neurology
Accepting new patients
Call for an appointment
or

    About me

    Dr. Jayant Acharya recently joined Southern Illinois University School of Medicine as Professor and Chair of the Department of Neurology and Executive Director of the Neuroscience Institute.

    Dr. Acharya obtained his medical school training followed by residencies in Internal Medicine and Neurology in India before moving to the United States, where he completed a residency in Neurology at Wake Forest University School of Medicine and a fellowship in Epilepsy and Clinical Neurophysiology at the Cleveland Clinic Foundation. Subsequently, he worked as an Assistant Professor of Neurology at the University of Pittsburgh and Associate Professor of Neurology at Saint Louis University before moving to Penn State University as a tenured Professor of Neurology, and Chief of the Division of Epilepsy and Co-Director of the Clinical Neurophysiology Lab.

    He is the recipient of numerous honors and academic, research and teaching awards, and is listed in Best Doctors in America. He has been elected as a fellow of the American Epilepsy Society, American Clinical Neurophysiology Society, American Academy of Neurology and American Neurological Association.

    Dr. Acharya has authored several publications on all aspects of epilepsy and has been a manuscript and book reviewer for numerous leading journals. He is on the editorial board of Clinical Neurophysiology Practice and the Journal of Clinical Neurophysiology. He is a member of various local, regional, national and international committees and served as Chair of the Self-Assessment in Epilepsy Committee, and Vice-Chair of the Educational and Professional Development Committee of the American Epilepsy Society. Dr. Acharya has twice received the Dean's Award for Excellence in Teaching and Scholarship in Education awards, and been honored with the title of Distinguished Educator at Penn State College of Medicine. He has been an invited speaker and panelist at a number of regional, national, and international conferences.

    Treatments Offered: 
    Epilepsy-medical, surgical and neurostimulation EEG interpretation including routine, ambulatory, continuous EEG and noninvasive and invasive video-EEG monitoring Neurological disorders

     

    Gender

    Male

    Education & training

    Positions
    Professor and Chair, Department of Neurology
    Co-Executive Director of the Neuroscience Institute
    Board Certifications
    Neurology
    Epilepsy
    Sleep Medicine
    Clinical Neurophysiology
    Medical School
    M.B.B.S, B.J. Medical College, Pune, India
    M.D, Internal Medicine, B.J. Medical College, Pune, India
    D.M., Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India
    Residency
    Internal Medicine, B.J. Medical College, Pune, India
    Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India
    Neurology with 1-year internship in Internal Medicine, Wake Forest University Medical Center, Winston-Salem, NC
    Fellowship
    Epilepsy and Clinical Neurophysiology, Cleveland Clinic Foundation, Cleveland, OH

    Specialties

    Treatments & procedures

    Clinical locations

    Locations

    SIU Neuroscience Institute

    751 N. Rutledge St. Springfield, IL 62702 Suite 3100
    Mon - Fri: 8:00 am-4:30 pm
    Locations

    SIU Neurology Clinic

    751 N. Rutledge St. Springfield, IL 62702 Suite 3100
    Mon - Fri: 8:00 am-4:30 pm

    Clinical trials

    Trial
    Neurology

    A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

    Active recruiting

    The primary objective is to assess the effect of XEN1101 versus placebo on reducing PGTCS frequency in subjects with PGTCS.

    Trial
    Neurology

    A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures

    Active recruiting

    The primary objective of this study is to assess the effect of XEN1101 versus placebo on reducing focal seizure frequency.

    Trial
    Neurology

    An Open-Label, Multicenter, Outpatient Extension Study to Evaluate the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older with Stereotypical Prolonged Seizures

    Active recruiting

    The primary endpoint of this study is to evaluate the long-term safety and tolerability of Staccato alprazolam.

    Trial
    Neurology

    A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Outpatient, Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older with Stereotypical Prolonged Seizures

    Active recruiting

    The purpose of this study is to compare the success of a single admnistration of Staccato alprazolam compared with placebo in rapidly terminating a seizure episode within 90seconds after IMP administration.

    Related articles

    Jayant Acharya

    Acharya named Neurology chair and co-director of SIU Neuroscience Institute

    Dr. Jayant Acharya has been named the chair of the Department of Neurology and co-executive director of the Neuroscience Institute at Southern Illinois University School of Medicine.